Cerebral Arteriovenous Malformation With Aneurysm: Epidemiology, Clinical Features, and Prognosis
Starting soon
Conditions studied: Cerebral Arteriovenous Malformation, Intracranial Arterial Diseases, Intra Cerebral Hemorrhage, Intracranial Aneurysm, Brain Diseases
In brief
The study is a multicenter, prospective cohort study designed to assess the natural history, clinical safety and efficacy of various treatment strategies in patients with cerebral arteriovenous malformations (AVMs) and intracranial aneurysms.
Key facts
- Study ID
- NCT07353736
- Run by
- Duan Chuanzhi
- People needed
- 630
- Starts
- 2026-02-01
- Expected to finish
- 2030-12-30
- Last updated by the study team
- 2026-01-20
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients diagnosed with cerebral arteriovenous malformation and intracranial aneurysm confirmed by CTA, MRA, and/or DSA;
- Availability of complete clinical and imaging data;
- Provision of written informed consent by the patient or their legally authorized representative to participate in the study and undergo follow-up;
- Not concurrently participating in any other clinical trials that may interfere with the outcomes of this study.
You may not qualify if…
- Previous complete occlusion of the aneurysm and/or arteriovenous malformation prior to enrollment;
- Coexistence of other cerebrovascular diseases such as moyamoya disease, cerebral cavernous malformation, cerebral venous sinus thrombosis, etc.;
- Absence of DSA imaging data or poor image quality that precludes accurate evaluation of key anatomical and hemodynamic parameters of the AVM and intracranial aneurysm.
Where it is running
- Zhujiang Hospital, Southern Medical University — Guangzhou, Guangdong, China
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.